205 related articles for article (PubMed ID: 37029861)
21. Blastic plasmacytoid dendritic cell neoplasm of the breast: A case report and review of the literature.
Lee HJ; Park HM; Ki SY; Choi YD; Yun SJ; Lim HS
Medicine (Baltimore); 2021 May; 100(19):e25699. PubMed ID: 34106594
[TBL] [Abstract][Full Text] [Related]
22. Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023.
Pemmaraju N; Kantarjian H
Clin Adv Hematol Oncol; 2023 May; 21(5):257-264. PubMed ID: 37145496
[TBL] [Abstract][Full Text] [Related]
23. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
Liao C; Hu NX; Song H; Zhang JY; Shen DY; Xu XJ; Tang YM
Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
[TBL] [Abstract][Full Text] [Related]
24. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
[TBL] [Abstract][Full Text] [Related]
25. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies.
Mehra S; Taylor J
Cells; 2024 Jan; 13(3):. PubMed ID: 38334635
[TBL] [Abstract][Full Text] [Related]
26. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
[TBL] [Abstract][Full Text] [Related]
27. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents.
Wang S; Wang X; Liu M; Bai O
Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234
[TBL] [Abstract][Full Text] [Related]
28. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
29. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
[TBL] [Abstract][Full Text] [Related]
30. Blastic plasmacytoid dendritic cell neoplasm.
Lim D; Goodman H; Rademaker M; Lamont D; Yung A
Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
[TBL] [Abstract][Full Text] [Related]
31. Blastic Plasmacytoid Dendritic Cell Neoplasm.
Khoury JD
Curr Hematol Malig Rep; 2018 Dec; 13(6):477-483. PubMed ID: 30350260
[TBL] [Abstract][Full Text] [Related]
32. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms.
Small C; Mukerjee S; Jangam D; Gollapudi S; Singh K; Jaye DL; Aung PP; Querfeld C; Yao K; Chisholm KM; Pullarkat S; Wang S; Gru A; Hussaini M; George TI; Ohgami RS
Int J Lab Hematol; 2023 Oct; 45(5):726-734. PubMed ID: 37282364
[TBL] [Abstract][Full Text] [Related]
33. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
[TBL] [Abstract][Full Text] [Related]
34. A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Ceribelli M; Hou ZE; Kelly PN; Huang DW; Wright G; Ganapathi K; Evbuomwan MO; Pittaluga S; Shaffer AL; Marcucci G; Forman SJ; Xiao W; Guha R; Zhang X; Ferrer M; Chaperot L; Plumas J; Jaffe ES; Thomas CJ; Reizis B; Staudt LM
Cancer Cell; 2016 Nov; 30(5):764-778. PubMed ID: 27846392
[TBL] [Abstract][Full Text] [Related]
35. Blastic Plasmacytoid Dendritic Cell Neoplasm-Current Insights.
Venugopal S; Zhou S; El Jamal SM; Lane AA; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):545-554. PubMed ID: 31281107
[TBL] [Abstract][Full Text] [Related]
36. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
37. Blastic Plasmacytoid Dendritic Cell Neoplasm without Cutaneous Manifestation: A Case Report.
Razzeto A; Garala P; Amoozgar B; Daliparty VM; Rehman F; Razzeto M
Am J Case Rep; 2021 Sep; 22():e932887. PubMed ID: 34550964
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological analysis of 46 cases with CD4
Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
[TBL] [Abstract][Full Text] [Related]
39. Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment.
Sweet K
Curr Opin Hematol; 2020 Mar; 27(2):103-107. PubMed ID: 31972688
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
